Clinical Development of MET Targeted Therapy For Human Cancer

E-ISSN： 1875-6301|5|4|261-270

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.5, Iss.4, 2009-11, pp. : 261-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Nanosystems for Cancer Therapy

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Biological Study for Met Expression to Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 1, 2010-01 ,pp. : 58-63

Bentham Science Publishers

Access to resources Recommend Favorite

The contribution of antibodies to targeted cancer therapy

By Apostolou Panagiotis Papasotiriou Ioannis

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 258-261

Springer Publishing Company

Access to resources Recommend Favorite

Aptamer applications for targeted cancer therapy

By Barbas Andrew S Mi Jing Clary Bryan M White Rebekah R

Future Oncology, Vol. 6, Iss. 7, 2010-07 ,pp. : 1117-1126

Future Medicine

Access to resources Recommend Favorite

Pancreatic cancer — Outlook: targeted therapy

By Michl Patrick Gress Thomas

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 2, 2007-04 ,pp. : 176-180

Springer Publishing Company

Access to resources Recommend Favorite